Ablation Devices Market Size By Technology (Electrical {Electrical Ablators, Electrical Brachytherapy}, Radiation {Brachytherapy, Stereotactic Radiotherapy and Radiosurgery, Image Guided Radiation Therapy, Intensity Modulated Radiation Therapy, Stereotactic Body Radiation Therapy, Proton Beam Therapy} Radiofrequency, Light {Cold Laser, Excimer Laser}, Ultrasound {High Intensity Focused Ultrasound, Magnetic Resonance Imaging Guided Focused Ultrasound, Ultrasonic Surgical System, Shock Wave Lithotripsy}, Cryotherapy {Tissue Contact Probe, Cryogen Spray Probe, Epidermal and Subcutaneous Cryoablation Device}, Thermal, Microwave, Hydromechanical), By Product (Disposable, Capital, Reusable), By Application (Cardiology, Oncology, Ophthalmology, Pain Management, Gynaecology, Urology, Orthopaedic Treatment, Cosmetic Surgery), By End Use (Hospitals, Ambulatory Surgical Centers, Others), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025

Published Date: Jun 2019  |  Report ID: GMI3419  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 300   |   Base Year: 2018




Summary Table of Contents Industry Coverage Methodology

Industry Trends

Ablation Devices Market size was valued at USD 12.7 billion in 2018 and is expected to witness 10.4% CAGR from 2019 to 2025. Increasing adoption of minimally invasive techniques, increasing ablation procedures, growing geriatric population, rising cases of cancer coupled with growing healthcare awareness will augment the market growth. Moreover, improving medical reimbursements and advancement in healthcare technology are factors fueling the market growth. 
 

Ablation Devices Market

Get more details on this report - Request Free Sample PDF
 

However, stringent government approval is one of the major reasons hindering the adoption rates. Also, complications related to ablation procedures, reuse of ablation devices in developing economies and high cost associated with ablation procedures might hamper the market growth in certain emerging regions.
 

Ablation Devices Market Report Coverage
Report Coverage Details
Base Year: 2018 Market Size in 2018: 12.7 Billion (USD)
Historical Data for: 2014 to 2018 Forecast Period: 2019 to 2025
Forecast Period 2019 to 2025 CAGR: 10.4% 2025 Value Projection: 25 Billion (USD)
Pages: 300 Tables, Charts & Figures: 550
Geographies covered (16): U.S., Canada, Germany, UK, France, Italy, Spain, China, Japan, India, Australia, Singapore, Brazil, Mexico, South Africa, Saudi Arabia
Segments covered: Technology, Product, Application, End Use and Region
Companies covered (11): Medtronic Plc, Boston Scientific, Abbott Laboratories, Alcon Laboratories, Angiodynamics, Atricure, Biosense Webster, CONMED, Elekta AB, Varian, Johnson and Johnson
Growth Drivers:
  • Increasing incidence of cancer
  • Rising demand for minimally invasive procedures
  • Advancement in healthcare technology
  • Growing geriatric population base
Pitfalls & Challenges:
  • High cost and risk associated with ablation procedures
  • Stringent regulatory approvals

Get more details on this report - Request Free Sample PDF
 

Ablation Devices Market, By Application

Germany Ablation Devices Market By Application

Get more details on this report - Request Free Sample PDF
 

Pain management segment is projected to expand at a CAGR of 10.8% over the estimation period from 2019 to 2025. Pain management ablation is a minimally invasive procedure in which the nerve fibers carrying pain signals to the brain are destroyed to reduce or stop the pain. This procedure provides relief for people with chronic pain in parts such as arthritic joints, lower back and neck, hence propelling the ablation devices industry growth.
 

Oncology ablation devices market was valued at USD 4,173.8 million in 2018 and is estimated to witness a considerable growth in the future. The market growth is attributed to better potential benefits than other medical treatments of cancer and lower post procedure stay in hospital in comparison to open surgery. 
 

By Product

Disposable product segment was valued at USD 5158.9 million in 2018. This segment is expected to grow at the highest CAGR during the forecast period due to low cost and repeated demand from end-users for ablation procedures. 
 

Reusable ablation devices market will grow at 10.3% through 2025. This growth is attributed to factors such as reduction in medical waste associated with reusable ablation devices and lower costs. 
 

By End-use

Application of ablation devices are the highest in hospitals resulting in major market share. The hospitals segment accounted for USD 7,912.5 million revenue in 2018. A substantial proportion of ablation procedures happen in hospital settings with the budget of hospitals being higher than other healthcare settings. During the forecast period, the hospitals end-use segment will continue to remain the largest market, owing to increasing ablation procedures in hospital settings coupled with rising supply agreements of ablation devices between manufacturing firms and hospitals. 
 

Ambulatory surgical centers are forecast to expand at 11% CAGR up to 2025. These are the most preferred setting in developed as well as developing countries. Others segment includes private clinics and other similar establishments run by single or a group of doctors. This segment has lowest market share as the budget is lower as compared to hospitals and ambulatory surgical centers. 
 

Regional Insights

Europe Ablation Devices Market By Country

Get more details on this report - Request Free Sample PDF
 

U.S. dominated the North America ablation devices market, valued at USD 4,902.1 million in the year 2018. High disposable income and various reimbursement policies will enable patients to opt for ablation procedures. Growing influence for minimally invasive medical devices will aid the growth of ablation devices business. Moreover, rising prevalence of cancer will foster country growth in foreseeable years. In future years, costs are likely to increase as the population ages and cancer prevalence increases. 
 

Asia Pacific will observe rapid growth rate of 11.2% through 2025. Emerging economies like India and China will boost the overall market growth owing to favorable government policies, growing healthcare awareness and increasing healthcare expenditure.  

Competitive Market Share

Medtronic Plc, Boston Scientific, Abbott Laboratories, Alcon Laboratories, Angiodynamics, Atricure, Biosense Webster, CONMED, Elekta AB, Varian, Johnson and Johnson are some of the major players operating effectively in the ablation devices market share. These key market participants will hold majority market share owing to strong financial position and better brand recognition. Major strategies implemented by these companies in the market include new product launches, expansion strategy, acquisition strategy, etc. with the aim to gain competitive advantage over its peers. For instance, in October 2015, AtriCure Inc. announced definitive merger agreement under which Atricure had agreed to acquire nContact Inc., a privately-held developer of innovative cardiac ablation products
 

Ablation devices have been in use for percutaneous coronary intervention and peripheral vascular intervention since late 1980’s and numerous upgradations have been done for optimal results. Ablation is a medical procedure for the removal of tissue by less invasive techniques. It is used to treat several medical conditions ranging from serious to cosmetic. The devices used in these procedures are called ablation devices. This industry is rapidly growing in both developed as well as developing economies. The market is growing at immense pace in developed countries owing to various technological advancements and increasing cases of cancer.
 

Demographic changes and high incidence of cancer and cardiovascular diseases across the globe will propel the growth of global market. The industry is witnessing large number of new entrants that are engaged in the development of advanced ablation devices with miniaturization to generate higher revenue. With advancements in existing technologies and rising demand of minimally invasive surgical procedures, ablation devices industry will offer promising growth opportunities in the near future.
 

Frequently Asked Questions (FAQ) :

The market size of ablation devices exceeded USD 12.7 billion in 2018.
The industry share of ablation devices is projected to grow at 10.4% CAGR up to 2025.
An increase in preference for minimally invasive techniques, rising geriatric population, and increasing cases of cancer are fueling the demand for ablation devices.
Factors like complications pertaining to ablation procedures, reuse of ablation devices across developing nations, and high cost associated with procedures may negatively impact the market for ablation devices.
Currently, Medtronic Plc, Abbott Laboratories, Alcon Laboratories, Boston Scientific, Atricure, Biosense Webster, CONMED, Angiodynamics, Elekta AB, Johnson and Johnson and Varian are some of the key manufacturers of ablation devices.
Availability of high disposable income, growing influence towards minimally invasive medical devices and rising prevalence of cancer have bolstered the demand for ablation devices across North America.

Buy Now

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Premium Report Details

  • Published Date: Jun 2019
  • Pages: 300
  • Tables: 541
  • Charts / Figures: 9
  • Companies covered: 11
  • Countries covered: 16

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

GMIPulse, our report store

We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X